137 related articles for article (PubMed ID: 12724915)
1. Growth factor expression in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
Pollan MC; Benghuzzi HA; Tucci M
Biomed Sci Instrum; 2003; 39():329-34. PubMed ID: 12724915
[TBL] [Abstract][Full Text] [Related]
2. Physiological responses associated with sustained delivery of T, DHT, and AED in male rats.
Stokes KI; Benguzzi HA; Cameron JA
Biomed Sci Instrum; 2000; 36():209-14. PubMed ID: 10834234
[TBL] [Abstract][Full Text] [Related]
3. Cytopathological changes in early stages of benign prostatic hyperplasia upon exposure to sustained delivery of androgens.
Pollan MC; Benghuzzi HA; Tucci M
Biomed Sci Instrum; 2002; 38():15-20. PubMed ID: 12085593
[TBL] [Abstract][Full Text] [Related]
4. The analysis of the dorsal aorta and renal vessels exposed to sustained delivery of AED, T, and DHT using a rat model.
Credit SL; Benghuzzi HA; Tucci M; Farah I; Cameron JA
Biomed Sci Instrum; 2003; 39():511-6. PubMed ID: 12724944
[TBL] [Abstract][Full Text] [Related]
5. Morphometric analysis of the adrenal compartments exposed to sustained delivery of androgens.
Pope JA; Benghuzzi H; England B; Cason Z
Biomed Sci Instrum; 2001; 37():155-60. PubMed ID: 11347380
[TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of sustained delivery of DHT, DHEA, and E on the ventral prostate of adult male rodents.
Cavett W; Cason Z; Tucci M; Puckett A; Benghuzzi H
Biomed Sci Instrum; 1997; 34():30-5. PubMed ID: 9603008
[TBL] [Abstract][Full Text] [Related]
7. Prevalent decrease of the EGF content in the periurethral zone of BPH tissue induced by treatment with finasteride or flutamide.
Monti S; Sciarra F; Adamo MV; Toscano V; Trotta MC; Martini C; Lanzara S; Silverio FD
J Androl; 1997; 18(5):488-94. PubMed ID: 9349746
[TBL] [Abstract][Full Text] [Related]
8. Cellular responses to various levels of sustained delivery of testosterone in the ventral prostate.
Cavett W; Tucci M; Cason Z; Lemos L; England B; Tsao A; Benghuzzi H
Biomed Sci Instrum; 1997; 33():155-60. PubMed ID: 9731352
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of cytokine expression in tissue-implant response associated with TCP bioceramic implants loaded with steroid hormones.
Butler KR; Benghuzzi HA
Biomed Sci Instrum; 2003; 39():541-6. PubMed ID: 12724949
[TBL] [Abstract][Full Text] [Related]
10. Localization of cytokines in heart ventricular and apex tissues exposed to sustained delivery of AED, T, and DHT using a rat model.
Credit SL; Benghuzzi HA; Tucci M; Farah I; Cameron JA
Biomed Sci Instrum; 2002; 38():95-100. PubMed ID: 12085665
[TBL] [Abstract][Full Text] [Related]
11. Morphometric analysis of the hormonal effect on tissue-implant response associated with TCP bioceramic implants.
Butler KR; Benghuzzi HA
Biomed Sci Instrum; 2003; 39():535-40. PubMed ID: 12724948
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of prostatic acid phosphatase and prostate-specific antigen mRNA levels in hyperplastic prostate stimulated with steroid hormones and growth factors.
Dulińska J; Laidler P; Labedź M
Acta Biochim Pol; 2002; 49(2):357-68. PubMed ID: 12362977
[TBL] [Abstract][Full Text] [Related]
13. Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia.
Soulitzis N; Karyotis I; Delakas D; Spandidos DA
Int J Oncol; 2006 Aug; 29(2):305-14. PubMed ID: 16820871
[TBL] [Abstract][Full Text] [Related]
14. Effects of long-term administration of androgens and estrogen on rhesus monkey prostate: possible induction of benign prostatic hyperplasia.
Jeyaraj DA; Udayakumar TS; Rajalakshmi M; Pal PC; Sharma RS
J Androl; 2000; 21(6):833-41. PubMed ID: 11105909
[TBL] [Abstract][Full Text] [Related]
15. [Growth factors and benign prostatic hyperplasia].
Boroian R
Georgian Med News; 2007 Nov; (152):18-22. PubMed ID: 18175827
[TBL] [Abstract][Full Text] [Related]
16. Morphometric analysis of cortical bone upon the exposure to sustained delivery of anabolic promoting agents using adult male rats as a model.
Tramontana J; Benghuzzi H; Tucci M; Tsao A; Hughes J
Biomed Sci Instrum; 2001; 37():293-8. PubMed ID: 11347405
[TBL] [Abstract][Full Text] [Related]
17. Functional and anatomical effects of hormonally induced experimental prostate growth: a urodynamic model of benign prostatic hyperplasia (BPH) in the beagle.
Yokota T; Honda K; Tsuruya Y; Nomiya M; Yamaguchi O; Gotanda K; Constantinou CE
Prostate; 2004 Feb; 58(2):156-63. PubMed ID: 14716740
[TBL] [Abstract][Full Text] [Related]
18. Inflammation and epithelial alterations in rat prostate: impact of the androgen to oestrogen ratio.
Yatkin E; Bernoulli J; Talvitie EM; Santti R
Int J Androl; 2009 Aug; 32(4):399-410. PubMed ID: 19515173
[TBL] [Abstract][Full Text] [Related]
19. Benign prostatic hyperplasia and growth factors.
Lawson RK
Urologe A; 1990 Jan; 29(1):5-7. PubMed ID: 1690485
[TBL] [Abstract][Full Text] [Related]
20. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
